Platelet aggregation inhibitors excl. heparin

Ticlopidine Hydrochloride

Approved 13 Sept 1999OralTablet

The FDA lists this product in 9 strengths and forms.

Official labelAsk Osler about it

Composition

Active ingredients: TICLOPIDINE HYDROCHLORIDE 250MG

Strengths and forms

The FDA lists each strength of a product separately; these pages share one label.

Official product information

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Drugs@FDA lists the approved labels, letters and reviews for application ANDA075161.

Open Drugs@FDA

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Brand name: Ticlopidine Hydrochloride
Drug class: Platelet aggregation inhibitors excl. heparin
Group: Anticoagulants and antiplatelets
Route: Oral
Dosage form: Tablet
Applicant: Mylan
Status: Discontinued
FDA approval: 13 Sept 1999
Application: ANDA075161-001
RxCUI: 97

Guidelines

FDA 2025

CangrelorPowder

RivaroxabanFor suspension

Xareltorivaroxaban · For suspension

Uptraviselexipag · Powder

Angiomax Rtubivalirudin · Solution

Argatroban in Sodium Chlorideargatroban · Solution

TicagrelorTablet

Bivalirudin in 0.9% Sodium Chloridebivalirudin · Solution

TreprostinilInjectable

Prasugrelprasugrel hydrochloride · Tablet

Dabigatran Etexilate MesylateCapsule

BivalirudinInjectable

Durlazaaspirin · Capsule, extended release

EptifibatideInjectable

Vazaloreaspirin · Capsule

Eliquisapixaban · Tablet